---
title: "rufinamide - Lennox-Gastaut syndrome"
sidebar: mydoc_sidebar
permalink: rufinamidelennoxgastautsyndrome.html
toc: false 
---

{% include image.html url="images/rufinamidelennoxgastautsyndrome.png" file="rufinamidelennoxgastautsyndrome.png" alt="rufinamidelennoxgastautsyndrome" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C079703 | rufinamide | Drug |
| UniProt:Q15858 | Sodium channel protein type 9 subunit alpha | Protein |
| GO:0019228 | neuronal action potential | BiologicalProcess |
| GO:0007269 | neurotransmitter secretion | BiologicalProcess |
| HP:0032792 | Tonic seizure | PhenotypicFeature |
| MESH:D065768 | Lennox-Gastaut syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Rufinamide | DECREASES ACTIVITY OF | Sodium Channel Protein Type 9 Subunit Alpha |
| Sodium Channel Protein Type 9 Subunit Alpha | POSITIVELY REGULATES | Neuronal Action Potential |
| Neuronal Action Potential | POSITIVELY CORRELATED WITH | Neurotransmitter Secretion |
| Neurotransmitter Secretion | POSITIVELY CORRELATED WITH | Tonic Seizure |
| Tonic Seizure | POSITIVELY CORRELATED WITH | Lennox-Gastaut Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB06201#mechanism-of-action](https://go.drugbank.com/drugs/DB06201#mechanism-of-action){:target="_blank"}